NPR

Colonoscopies save lives. Doctors push back against European study that casts doubt

Colon cancer specialists worry that results of a study published this week in the New England Journal of Medicine could be misconstrued, and keep patients from getting lifesaving cancer screening.
A new European study grabbed headlines this week, as it seemed to question the efficacy of colonoscopies as a cancer screening tool. But U.S. physicians say there were big limits to that study. They cite more than a decade of research showing colonoscopies save lives.

The findings of a big European study published in the New England Journal of Medicine this week seemed to cast doubt on just how beneficial a colonoscopy is in preventing colorectal cancer, which is a leading cause of cancer deaths in the U.S. The results have generated a lot of controversy and buzzy headlines in the popular press — such as "Screening Procedure Fails to Prevent Colon Cancer Deaths in Large Study."

But that's not the whole story.

A colonoscopy is a widely recommended tool for cancer screening that involves putting a scope into the colon to look for potentially cancerous growths, called polyps, and cutting them out. Sometimes these slow-growing polyps — or adenomas —to cancer, so by looking periodically and removing any polyps, the procedure serves as both a screening tool for cancer and an intervention to prevent a tumor from developing in the first place.

You’re reading a preview, subscribe to read more.

More from NPR

NPR2 min read
Peloton Is Laying Off Workers And Replacing The CEO — Again
It's déjà vu for the luxury fitness company: Peloton is cutting about 400 more jobs, and its CEO is stepping down just two years after a major shakeup.
NPR7 min readAmerican Government
Trump Trial Coverage
The news media face a number of temptations while covering the criminal trial of former President Donald Trump, including dwelling on salacious details, overdramatizing insignificant moments, and getting distracted by out-of-court behaviors that have
NPR1 min readAmerican Government
FTC Bars Former Pioneer CEO In Exxon Mobil Deal, Saying He Colluded With OPEC
Exxon Mobil's $60 billion deal to buy Pioneer Natural Resources received federal clearance, but former Pioneer CEO Scott Sheffield was barred from joining the new company's board of directors.

Related Books & Audiobooks